Zhang Die, Peng Jianding, Zhu Yingjie, Gong Qiang, Wang Qing, Xiang Chaodong, Du Hanjian, Hu Xiaofei
Department of Neurology, The First Hospital Affiliated of Army Medical University (Southwest Hospital), Chongqing, China.
Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Front Oncol. 2025 Apr 8;15:1513296. doi: 10.3389/fonc.2025.1513296. eCollection 2025.
This study provides a comprehensive bibliometric analysis of research trends in Positron Emission Tomography/Computed Tomography (PET/CT) applications for lymphoma, aiming to identify key contributors, emerging topics, and collaboration patterns within the field.
Data from the Web of Science Core Collection (2004-2024) were analyzed. Original articles and reviews in English on PET/CT in lymphoma staging, response assessment, or prognosis were included, while case reports, meeting abstracts, and editorials were excluded. Using CiteSpace, VOSviewer, and Bibliometrix R, we evaluated country/institutional contributions, co-citation networks, keyword trends, and employed linear regression for trend forecasting.
A total of 2,962 papers related to PET/CT and lymphoma were published during the study period. The annual publication volume increased significantly, peaking in 2021 with 281 papers, followed by a decline to 260 in 2023, potentially linked to COVID-19-related research disruptions. The United States and China led in publication volume, contributing over 40% of global publications. Leading institutions included UNICANCER and Assistance Publique Hôpitaux de Paris. Influential authors such as Sally F. Barrington and Michel Meignan were identified. The European Journal of Nuclear Medicine and Molecular Imaging and the Journal of Nuclear Medicine were the top journals in this field. Key research themes included staging, response assessment, prognosis, and the role of PET/CT in personalized treatment approaches.
This bibliometric analysis highlights the significant growth and evolving trends in PET/CT research for lymphoma. The findings underscore the critical role of PET/CT in advancing precision medicine, informing future research directions, and optimizing clinical practices in lymphoma management.
本研究对正电子发射断层扫描/计算机断层扫描(PET/CT)在淋巴瘤应用中的研究趋势进行了全面的文献计量分析,旨在识别该领域的关键贡献者、新兴主题和合作模式。
分析了来自科学网核心合集(2004 - 2024年)的数据。纳入了关于PET/CT在淋巴瘤分期、疗效评估或预后方面的英文原创文章和综述,排除了病例报告、会议摘要和社论。使用CiteSpace、VOSviewer和Bibliometrix R,我们评估了国家/机构贡献、共被引网络、关键词趋势,并采用线性回归进行趋势预测。
在研究期间共发表了2962篇与PET/CT和淋巴瘤相关的论文。年发表量显著增加,在2021年达到峰值,有281篇论文,随后在2023年降至260篇,这可能与COVID - 19相关的研究中断有关。美国和中国在发表量方面领先,占全球发表量的40%以上。领先机构包括UNICANCER和巴黎公共救助医院集团。识别出了诸如萨利·F·巴林顿和米歇尔·梅尼昂等有影响力的作者。《欧洲核医学与分子成像杂志》和《核医学杂志》是该领域的顶级期刊。关键研究主题包括分期、疗效评估、预后以及PET/CT在个性化治疗方法中的作用。
本文献计量分析突出了PET/CT在淋巴瘤研究中的显著增长和演变趋势。研究结果强调了PET/CT在推进精准医学、为未来研究方向提供信息以及优化淋巴瘤管理临床实践方面的关键作用。